Anaphylaxis
Publication Date: December 17, 2023
Key Points
Key Points
- Anaphylaxis is an acute, potential life-threatening systemic allergic reaction that may have a wide range of clinical manifestations.
- Severe anaphylaxis and/or the need for repeated doses of epinephrine to treat anaphylaxis are risk factors for biphasic anaphylaxis.
- Antihistamines and/or glucocorticoids are not reliable interventions to prevent biphasic anaphylaxis.
Diagnosis
...iagnosis...
...nt Task Force suggests that a clinician i...
...orce suggests extended clinical obs...
Treatment
Treatm...
...k Force suggests against administering glucocor...
...k Force suggests in favor of admini...
...int Task Force suggests against routinel...
...t Task Force suggests in favor administering o...
...Practice Statements...
...nephrine as the first-line pharmacotherap...
...y the administration of epinephrine...
...gnosis and treatment of anaphylaxis,...
...s with anaphylaxis should receive educa...
Suggested Key Clinical...
...Severe anaphylaxis and/or the need fo...
Illustrati...